bf/NYSE:BMY_icon.jpeg

NYSE:BMY

Bristol Myers Squibb

  • Stock

USD

Last Close

53.25

28/03 20:00

Market Cap

101.13B

Beta: 0.43

Volume Today

9.40M

Avg: 7.82M

PE Ratio

11.94

PFCF: 8.37

Dividend Yield

4.80%

Payout:57.08%

Share Trends

Feb 19Sep 20Apr 22Nov 23-300K-200K-100K0100K

Recent Transactions

Reporter Filed at Change (shares)
Holzer Phil M
SVP and Controller
Common Stock, $0.10 par value
2024-03-12
2.45K
24.46%
Hoch Lynelle
President, Cell Therapy Org.
Common Stock, $0.10 par value
2024-03-12
1.73K
100%
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
Common Stock, $0.10 par value
2024-03-12
13.03K
27.59%
Lenkowsky Adam
EVP, Chief Commercial Officer
Common Stock, $0.10 par value
2024-03-12
6.12K
1,164.26%
Leung Sandra
EVP, General Counsel
Common Stock, $0.10 par value
2024-03-12
15.97K
4.82%

Largest Transactions

Reporter Filed at Change (shares)
Bancroft Charles A
EVP, Head of Integration
Common Stock, $0.10 par value
2020-03-12
-285.90K
−72.88%
Leung Sandra
EVP, General Counsel
Common Stock, $0.10 par value
2023-11-24
-247.81K
−72.62%
Caforio Giovanni
Board Chair and CEO
Common Stock, $0.10 par value
2023-02-08
-240K
−50.41%
Leung Sandra
EVP, General Counsel
Common Stock, $0.10 par value
2020-08-17
-141.42K
−24.63%
Caforio Giovanni
Board Chair and CEO
Common Stock, $0.10 par value
2023-03-14
65.84K
27.89%

Transaction Log

Filing Date Transaction Date Reporter Title Post Shares Quantity T Stock Class USD
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
2.22K
1.70K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
10.71K
210
F
Common Stock, $0.10 par value
-11.30K
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
181.06K
8.04K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
377
97
F
Common Stock, $0.10 par value
-5.22K
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
3.40K
1.44K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
10.92K
121
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
1.96K
267
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
12.75K
2.43K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
60.28K
9.77K
F
Common Stock, $0.10 par value
-525.74K
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
726
349
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
529
99
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
4.84K
4.14K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
513
194
F
Common Stock, $0.10 par value
-10.44K
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
11.04K
701
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
1.44K
518
F
Common Stock, $0.10 par value
-27.86K
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
7.52K
246
F
Common Stock, $0.10 par value
-13.23K
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
8.20K
283
F
Common Stock, $0.10 par value
-15.22K
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
15.18K
6.99K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
50.78K
660
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
70.05K
10.20K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
12.46K
992
F
Common Stock, $0.10 par value
-53.36K
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
2.65K
2.09K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
561
105
F
Common Stock, $0.10 par value
-5.65K
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
628
628
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
1.03K
690
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
701
207
F
Common Stock, $0.10 par value
-11.13K
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
454
85
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
707
94
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
1.73K
917
F
Common Stock, $0.10 par value
-49.33K
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
10.34K
187
F
Common Stock, $0.10 par value
-10.06K
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
524
318
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
6.65K
3.23K
F
Common Stock, $0.10 par value
-174.01K
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
7.92K
994
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
7.76K
157
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
400.95K
23.82K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
8.48K
201
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
377.13K
10.09K
F
Common Stock, $0.10 par value
-542.63K
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
387.22K
3.69K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
479.92K
49.74K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
51.44K
4.19K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
53.01K
842
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
80.26K
29.31K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
13.86K
11.42K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
13.45K
1.46K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
3.01K
328
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
3.34K
1.90K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
474
50
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
666
60
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
1.93K
729
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Gallman Cari
EVP, Corporate Affairs
1.43K
494
F
Common Stock, $0.10 par value
-26.57K
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
194.97K
13.35K
F
Common Stock, $0.10 par value
-717.83K
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
337
192
F
Common Stock, $0.10 par value
-10.33K
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
208.31K
16.80K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
908
119
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Poole Ahn Amanda
EVP, Chief Human Resources
2.42K
976
F
Common Stock, $0.10 par value
-52.50K
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
539
539
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
257
197
F
Common Stock, $0.10 par value
-10.60K
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
801
544
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
3.78K
3.27K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Hoch Lynelle
President, Cell Therapy Org.
2.64K
1.14K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
10.62K
613
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
10.53K
97
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
396.84K
4.10K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
8.68K
1.16K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Plenge Robert M
EVP, Chief Research Officer
11.31K
1.44K
F
Common Stock, $0.10 par value
-77.24K
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
337.20K
5.79K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
336.29K
912
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
333.80K
2.49K
F
Common Stock, $0.10 par value
-133.94K
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
339.66K
5.86K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
338.65K
1.01K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
336.17K
2.48K
F
Common Stock, $0.10 par value
-133.13K
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
371.31K
35.14K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
359.08K
12.23K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Leung Sandra
EVP, General Counsel
347.39K
11.70K
F
Common Stock, $0.10 par value
-629.07K
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
176.64K
8.03K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
390.90K
23.41K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
225.11K
48.26K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
175.38K
1.26K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
176.85K
2.82K
F
Common Stock, $0.10 par value
-151.90K
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
173.02K
2.35K
F
Common Stock, $0.10 par value
-126.57K
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
529.66K
142.90K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
386.76K
10.08K
F
Common Stock, $0.10 par value
-542.42K
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
48.97K
1.81K
F
Common Stock, $0.10 par value
-97.20K
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
53.85K
4.88K
M
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Caforio Giovanni
Executive Chair of the Board
432.27K
47.65K
F
Common Stock, $0.10 par value
-2.56M
2024-03-12
2024-03-10
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
50.95K
2.07K
F
Common Stock, $0.10 par value
-111.24K
2024-03-12
2024-03-10
Elkins David V
EVP, Chief Financial Officer
179.68K
1.39K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
2.44K
570
F
Common Stock, $0.10 par value
-30.66K
2024-03-12
2024-03-10
Lenkowsky Adam
EVP, Chief Commercial Officer
9.88K
3.97K
J
Common Stock, $0.10 par value
0
2024-03-12
2024-03-10
Holzer Phil M
SVP and Controller
14.92K
4.21K
M
Common Stock, $0.10 par value
0
2023-11-24
2023-11-21
Leung Sandra
EVP, General Counsel
93.44K
9.83K
J
Common Stock, $0.10 par value
479.16K
2023-11-24
2023-11-21
Leung Sandra
EVP, General Counsel
331.41K
9.83K
J
Common Stock, $0.10 par value
-479.16K
2023-11-21
2023-11-20
Samuels Theodore R. Ii
Director
35.50K
8.50K
P
Common Stock, $0.10 par value
423.38K
2023-08-07
2023-08-03
Plenge Robert M
EVP, Chief Research Officer
6.58K
732
S
Common Stock, $0.10 par value
-44.75K
2023-05-04
2023-05-03
Vessey Rupert
EVP & President, Research
47.75K
50.38K
S
Common Stock, $0.10 par value
-3.38M
2023-04-04
2023-04-01
Shanahan Karin
EVP, Glob. Prod. Dev. & Supply
3.23K
1.69K
F
Common Stock, $0.10 par value
-117.27K
2023-04-04
2023-04-01
Mily Elizabeth
EVP, Strategy & BD
35.87K
2.68K
M
Common Stock, $0.10 par value
0
2023-04-04
2023-04-01
Mily Elizabeth
EVP, Strategy & BD
33.19K
2.06K
F
Common Stock, $0.10 par value
-142.71K
2023-04-04
2023-04-01
Mily Elizabeth
EVP, Strategy & BD
34.73K
1.14K
F
Common Stock, $0.10 par value
-78.94K
2023-04-04
2023-04-01
Mily Elizabeth
EVP, Strategy & BD
34.06K
3.66K
M
Common Stock, $0.10 par value
0

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.